Topical delivery of mTOR inhibitor halts scarring

J Dermatol Sci. 2019 Aug;95(2):76-79. doi: 10.1016/j.jdermsci.2019.06.008. Epub 2019 Jul 4.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Cicatrix / prevention & control*
  • Humans
  • Sirolimus / administration & dosage*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus